Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,632 | -71,658 | -62,034 | -43,069 | -16,494 |
| Depreciation Amortization | 361 | 1,218 | 904 | 626 | 317 |
| Accounts receivable | 2,397 | -2,061 | 1,036 | 224 | -141 |
| Other Working Capital | 333 | -10,585 | -5,606 | -4,463 | -7,377 |
| Other Operating Activity | 463 | 17,203 | 11,585 | 10,145 | 3,335 |
| Operating Cash Flow | $-13,078 | $-65,883 | $-54,115 | $-36,537 | $-20,360 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,527 | 18,857 | 12,368 | -19,803 | -16,046 |
| PPE Investments | -468 | -732 | -509 | -356 | -252 |
| Investing Cash Flow | $6,059 | $18,125 | $11,859 | $-20,159 | $-16,298 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,448 | 1,113 | 760 | 703 | 187 |
| Other Financing Activity | -4 | -776 | 0 | -534 | -2 |
| Financing Cash Flow | $3,444 | $337 | $760 | $169 | $185 |
| Beginning Cash Position | 22,061 | 69,482 | 69,482 | 69,482 | 69,482 |
| End Cash Position | 18,486 | 22,061 | 27,986 | 12,955 | 33,009 |
| Net Cash Flow | $-3,575 | $-47,421 | $-41,496 | $-56,527 | $-36,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,078 | -65,883 | -54,115 | -36,537 | -20,360 |
| Capital Expenditure | -468 | -732 | -509 | -356 | -252 |
| Free Cash Flow | -13,546 | -66,615 | -54,624 | -36,893 | -20,612 |